tamoxifen citrate peptide Tamoxifen citrate is a well-known selective estrogen receptor modulator - Tamoxifenmedchemexpress Tamoxifen is a selective estrogen receptor modulator (SERM Tamoxifen Citrate: A Deep Dive into its Role as an Estrogen Receptor Modulator in Cancer Therapy

Tamoxifenmolecular weight Tamoxifen citrate is a name frequently encountered in the realm of cancer treatment and research. It is primarily recognized as a selective estrogen receptor modulator (SERM), a class of drugs that play a crucial role in managing hormone-receptor-positive breast cancer. This non-steroidal drug has demonstrated significant efficacy as an antiestrogen with anti-cancer activity, making it a cornerstone in endocrine therapy. Its mechanism of action revolves around its ability to interact with estrogen receptors (ER), exhibiting a dual role as an antagonist in some tissues and a partial agonist in others. For instance, tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an ER agonist in the endometrium and as an ER antagonist in breast tissue, thereby inhibiting estrogen-driven tumor growth.Tamoxifen Citrate

The scientific literature, including numerous publications on platforms like PubMed, extensively documents the therapeutic applications and biochemical properties of tamoxifen citrate. Its journey from development to a widely used pharmaceutical is a testament to its impact. Originally developed as an estrogen analog compound, tamoxifen citrate has evolved into a vital drug for the prophylactic therapy of breast cancer. The NCI Dictionary of Cancer Terms defines tamoxifen citrate as a compound that exhibits these modulatory effects on estrogen receptors.

Understanding the Mechanism: How Tamoxifen Citrate Works

The efficacy of tamoxifen citrate lies in its precise interaction with the estrogen receptorTamoxifen Citrate (ICI 46474)is an orally active, selective estrogen receptor modulator(SERM) which blocks estrogen action in breast cells and can activate .... By selectively binding to these receptors, it blocks the effects of estrogen, a hormone that can fuel the growth of certain types of breast cancer.2025年8月10日—Tamoxifen citrate, a targeted anti-hormonal drug, plays a crucial role by suppressing estrogen in the body and blocking estrogen receptors, ... This estrogen receptor antagonist/partial agonist property is fundamental to its therapeutic action. In breast cancer cells, tamoxifen citrate functions as an antagonist, preventing estrogen from binding to its receptor and thereby halting the signaling pathways that promote cell proliferation. This action is critical for adjuvant treatment of early breast cancer in women with estrogen receptor-positive tumorsTamoxifen Citrate - BHB11900177.

Beyond its primary role as an ER antagonist in breast tissue, tamoxifen citrate also exhibits other biochemical actions.Tamoxifen Citrate - an overview It is identified as a Protein kinase C (PKC) inhibitor, and research suggests it induces apoptosis (programmed cell death) in estrogen receptor-positive cancer cells. Furthermore, studies highlight its potent inhibitory effect on mammalian sterol isomerase. Some research also points to its potential neuroprotective effects in femalesTamoxifen Citrate is a selective estrogen receptor modulator (SERM) widely utilized in the management of hormone receptor-positive breast cancer.. The molecular weight of tamoxifen citrate (often referred to with CAS RN® 54965-24-1) is approximately 563.65 g/mol, and it is typically available with a purity >99%, especially when intended for scientific or pharmaceutical testing, such as the Tamoxifen citrate FT32122 54965-24-1 cataloged by certain suppliers.

Clinical Applications and Research Horizons

The primary indication for tamoxifen citrate is the treatment and prevention of breast cancer. It is a vital component of therapy for individuals diagnosed with hormone receptor-positive breast cancer. The drug is available in various formulations, including tamoxifen citrate tablets, often sold under brand names like Nolvadex®. The FDA has approved NOLVADEX® - (Tamoxifen Citrate) - accessdata.fda.Tamoxifen (Citrate) - MedChem Expressgov for specific therapeutic uses. For example, MYLAN-TAMOXIFEN (tamoxifen citrate) is indicated for the adjuvant treatment of early breast cancer in women with estrogen receptor-positive tumors. Its use extends to preventing breast cancer in both women and men, underscoring its broad applicability.

Research continues to explore novel delivery systems and combinations for tamoxifen citrate.Tamoxifen Citrate - Antiestrogen drug - APExBIO For instance, studies have investigated tamoxifen citrate-loaded synthetic high-density lipoproteins and iRGD-guided tamoxifen polymersomes to enhance drug delivery and efficacy. The interaction of tamoxifen with other biological molecules, such as peptides, is also an area of interest. One study showed that a peptide derived from α-fetoprotein prevents the growth of estrogen-receptor-positive breast cancer xenografts, similar to the effect of tamoxifen.

For researchers and those involved in pharmaceutical testing, high-purity Tamoxifen Citrate is essential. Reputable suppliers offer reference standards for accurate results, ensuring the quality and performance of this crucial compound. When exploring options, one might encounter Tamoxifen citrate offered by specialized suppliers such as Peptide Pros, who have been active in the peptide and SARM marketTamoxifen.

In summary, tamoxifen citrate stands as a well-established and indispensable medication in the fight against breast cancer. Its targeted mechanism as a selective estrogen receptor modulator (SERM), coupled with its anti-cancer properties including the induction of apoptosis, solidifies its importance in modern oncology. The continuous research into its applications and delivery methods promises to further enhance its therapeutic potential.